ACTEON Group, a French MedTech company specializing in high-tech dental and medical equipment, has entered into exclusive negotiations with the Italian company VILLA SISTEMI MEDICALI (“VSM”), to acquire its Dental Division.

VSM Dental, based in Milan, designs, manufactures and markets digital imaging equipment such as PAN (panoramic X-Ray device) and CBCT (3D scanner), under the VILLA and OWANDY brands, and generates a global annual turnover of nearly €20 million.

With this operation, ACTEON Group now aims at becoming one of the top-5 global leaders in dental imaging by 2020. The latest ultra-compact technology of the VSM’s “Prime” PAN-CBCT range combined with the AIS reference software developed by ACTEON will bring to market a new range of highly innovative digital imaging equipment that will perfectly meet the dental practitioners’ needs.

This acquisition will strengthen the growth momentum of ACTEON, which achieved a strong operating performance in 2018, with a turnover close to €170 million driven by a +7% increase in the dental business, and an increase of more than 20% in EBITDA.

The bilateral discussions with VSM accelerated with the entry in October 2018 of DENTRESSANGLE as a majority shareholder, which has since brought together APRÈS-DEMAIN HOLDING, WEBER INVESTISSEMENTS, CARVEST and GSO CAPITAL companies as minority co-investors in ACTEON’s share capital.

Marie-Laure Pochon, CEO of ACTEON, said: « This operation allows us to unveil at the IDS Show currently being held in Cologne our new range of digital imaging devices which will be launched in May 2019, as well as the new Premium version of our CUBE product, thus enabling dentists to perform all types of surgery with quick, efficient and minimally invasive procedures. »

 

Thierry Coloigner, Managing Partner of DENTRESSANGLE Mid & Large Cap, added: « We fully support this external growth operation which is a strategic step towards making ACTEON a global leader in dental Imaging. ACTEON will now offer a complete range of extraoral imaging products to conquer new markets and accelerate its growth. We are proud to support the company in the next stages. »